Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001086878 | SCV000644870 | benign | Hypercholesterolemia, autosomal dominant, 3 | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000586453 | SCV000699991 | benign | not provided | 2017-02-23 | criteria provided, single submitter | clinical testing | Variant summary: The c.225C>T (p.Pro75=) in PCSK9 gene is a synonymous change that involves a non-conserved nucleotide. 5/5 programs in Alamut predict that this variant does not affect a normal splicing, however no functional studies supporting this notion were published at the time of evaluation. The variant is present in control population dataset of ExAC at a frequency of 0.0005568 (67/ 120328 chrs tested), predominantly in individuals of African descent (0.006325; 66/10276 chrs tested). The observed frequencies exceed the estimated maximal expected allele frequency of a pathogenic variant in PCSK9 gene (0.00009). The variant has not, to our knowledge, been reported in affected individuals via published reports or cited by a reputable database/clinical laboratory. Taking together, the variant was classified as Benign. |
Color Diagnostics, |
RCV000776137 | SCV000911124 | benign | Familial hypercholesterolemia | 2018-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000586453 | SCV001790738 | likely benign | not provided | 2021-02-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002448724 | SCV002733378 | likely benign | Cardiovascular phenotype | 2017-03-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV001086878 | SCV004844122 | benign | Hypercholesterolemia, autosomal dominant, 3 | 2024-02-05 | criteria provided, single submitter | clinical testing |